Alpha 2 Antiplasmin ANTIPLAS

Synonyms

Allscripts (AEHR) Order Name

Alpha 2 Antiplasmin

Sunrise Clinical Manager (SCM) Order Name

Alpha 2 Antiplasmin

EPIC Order Name

Alpha-2 Plasmin Inhibitor, Plasma

Clinical Info

Diagnosing congenital alpha-2 plasmin inhibitor deficiencies (rare) Providing a more complete assessment of disseminated intravascular coagulation, intravascular coagulation and fibrinolysis, or hyperfibrinolysis (primary fibrinolysis), when measured in conjunction with fibrinogen, fibrin D-dimer, fibrin degradation products, soluble fibrin monomer complex, and plasminogen Evaluating liver disease Evaluating the effects of fibrinolytic or antifibrinolytic therapy

Specimen Type

Container

Blue Top Tube

Collection Instructions

See Coagulation Studies in Special Instructions: Guidelines for
Specimen Handling and Processing.
 
Specimen Type:
Platelet-poor plasma
Collection
Container/Tube: Light-blue top (citrate)
Submission
Container/Tube: Plastic vial
Specimen Volume: 1
mL
Collection
Instructions:
1. Spin down, remove plasma, and spin plasma again.
2. Freeze specimen immediately at ?-40° C, if
possible.
Additional
Information:
1. Double-centrifuged specimen is critical for accurate results
as platelet contamination may cause spurious results.
2. Each coagulation assay requested should have its own
vial.
Specimen Type
Temperature
Time
Plasma Na Cit
Frozen
14 days
Coagulation Studies

Transport Instructions

Specimen Stability

Methodology

Chromogenic

Days Performed

Monday through
Friday; Varies

Performing Laboratory

Mayo Medical Laboratories

CPT

85410; LOINC Code: 27810-1;

PDM

5601205

Result Interpretation

Adults: 80-140%

Normal, full-term newborn infants may have borderline low or
mildly decreased levels (≥50%) which reach adult levels within 5
to 7 days postnatal.*

Healthy, premature infants (30-36 weeks gestation) may have
mildly d

Forms